Showing results (1561-1570 of 1,588) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|January 24, 2024
Clinical Features and Outcomes of Black Patients With MelanomaSophia N Wix, Ariel B Brown, Meghan Heberton, et al.
JAMA Dermatology|January 31, 2024
Short-Term Cardiovascular Complications in Dermatology Patients Receiving JAK-STAT Inhibitors: A Meta-Analysis of Randomized Clinical TrialsPatrick A Ireland, Nicholas Jansson, Sascha K R Spencer, et al.
JAMA Dermatology|September 18, 2024
Inherited Basaloid Neoplasms Associated With SUFU Pathogenic VariantsJames J Abbott, Angela J Jiang, Rama Godse, et al.
JAMA Dermatology|October 16, 2024
Hidradenitis Suppurativa and Maternal and Offspring OutcomesKaiyang Li, Vincent Piguet, David Croitoru, et al.
JAMA Dermatology|October 2, 2024
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in AdultsThomas Bettuzzi, Bénédicte Lebrun-Vignes, Saskia Ingen-Housz-Oro, et al.
JAMA Dermatology|October 2, 2024
Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-AnalysisPo-Yi Chou, Chia-Ling Yu, Chiao-Ni Wen, et al.
JAMA Dermatology|September 18, 2024
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical TrialsEric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, et al.
JAMA Dermatology|May 7, 2025
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical TrialMelinda J Gooderham, Javier Alonso-Llamazares, Jerry Bagel, et al.
JAMA Dermatology|March 26, 2025
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of MelanomaDaniel Lindsay, H Peter Soyer, Monika Janda, et al.
JAMA Dermatology|May 29, 2024
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing AlopeciaTuntas Rayinda, Sheila M McSweeney, Evangelos Christou, et al.
Pageof 159